Retinitis pigmentosa (RP) is a hereditary eye disease that seriously affects vision. It is like a creeping dark messenger, gradually depriving the patient of the light world. For many patients and families, RP brings not only vision loss, but also a great challenge to life. In this blog post, we will explore the causes of retinitis pigmentosa and what is currently available to improve it.
Cause of disease
1. Genetic factor
- RP is mainly caused by genetic defects. More than 60 genes are known to be associated with RP, and mutations in these genes can be inherited in autosomal dominant, autosomal recessive, or X-linked recessive ways.
- Different genetic mutations affect the structure and function of retinal cells, especially photoreceptor cells and retinal pigment epithelial cells. For example, certain genetic mutations cause degradation and death of photoreceptor cells, which can cause vision loss. People who have RP in their family have a significantly increased risk. Genetic counseling and genetic testing can help people with a family history understand their risk and take preventive measures accordingly.
2. Environmental factor
- Although genetic factors play a major role in the onset of RP, environmental factors may also have an impact on the development of the disease. Long-term exposure to bright light, especially ultraviolet and blue light, may accelerate damage to retinal cells. Smoking, poor nutrition, and exposure to certain drugs and chemicals may also increase the risk of developing RP.
- Maintaining a healthy lifestyle, such as avoiding bright light exposure, quitting smoking, eating a balanced diet, etc., can reduce the risk of developing RP to some extent or delay the progression of the disease.
Current means of improvement
1. Gene therapy
- Gene therapy is a promising treatment that works by introducing normal genes into a patient's retinal cells to correct diseases caused by genetic mutations. There are already several gene therapy clinical trials underway, and some preliminary results have shown some efficacy. For example, a gene therapy drug that targets RP caused by mutations in the RPE65 gene has been approved for marketing in the United States and Europe.
- The technology is still in the development stage, and there are some technical difficulties and risks.
2. Stem cell therapy
- Stem cell therapy involves transplanting stem cells into a patient's retina to replace damaged retinal cells. Stem cells can differentiate into various types of retinal cells, including photoreceptor cells and retinal pigment epithelial cells. At present, stem cell therapy for RP is still in the research stage, and some animal experiments have shown certain efficacy.
- At the same time, it also faces some challenges, such as the source of stem cells, the efficiency of differentiation, and immune rejection.
3. Low vision AIDS
- For people with RP, as the condition progresses, vision will gradually decline and may even lead to blindness. In this case, low vision AIDS can help patients improve their quality of life.
- For example, magnifying glasses, telescopes, electronic visual AIDS, etc., can help patients read, watch TV, recognize objects, etc. In addition, some special lighting equipment, such as high-brightness desk lamps, night lighting equipment, etc., can also provide a better visual environment for patients.
- Low vision rehabilitation training can help patients learn to use these assistive devices and improve their visual function and self-care ability.
4. Nutritional supplements
- Some nutrients, such as beta-carotene, lutein, zeaxanthin and other carotenoids, play an important role in the health of the retina.
- Research suggests that supplementing with these nutrients may help delay the progression of RP. A clinical study showed that after taking 9-cis-beta-carotene, the content of rhodopsin in the body was increased and the function of the retina was improved. In addition, lutein and zeaxanthin can absorb blue light and reduce retinal light damage.
- Carotenoids are the most acceptable and effective treatment to delay the symptoms of retinal degeneration by oral administration.
Conclusion
Retinitis pigmentosa is a serious hereditary eye disease for which there is no cure. However, improvement measures such as gene therapy, stem cell therapy, low vision AIDS, and nutritional supplements can delay the progression of the disease to a certain extent and improve the quality of life of patients. With the continuous progress of science and technology, we believe that there will be more effective treatments in the future, bringing bright hope for RP patients.
Reference:
[1] Min R ,Pierre B ,Régis D , et al.Treatment With 9- cis β-Carotene–Rich Powder in Patients With Retinitis Pigmentosa: A Randomized Crossover Trial[J].JAMA Ophthalmology,2013,131(8):1-8.
Note:
The above pictures are from the Internet, if there is infringement, please contact us to delete.